ClinicalTrials.gg
RecruitingNCT05867173Updated Nov 26, 2025

Perceptual Consequences of Cochlear Implant Electrode-neuron Interfaces

An interventional study of Experimental Speech Processing Strategy in Deafness, sponsored by Massachusetts Eye and Ear Infirmary. Recruiting at 2 sites in United States. Open to participants aged 3 Months and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-11-26.

Sponsored by Massachusetts Eye and Ear Infirmary · Not applicable, Interventional, and Other

From the registry’s dates

  • Registered 5 months after the study started (first participant enrolled Sep 2022, registered Feb 2023).
  • Started Sep 2022; still recruiting 4 years 1 month later.
Phase
Not applicable
Study type
Interventional
Enrollment
200
Allocation
Randomized
Ages
3 Months and older
Sex
All
01

Study summary

Despite the success of cochlear implants, devices surgically placed in the inner ears of patients with severe hearing loss, there remains substantial variability in the overall speech perception outcomes for the children and adults who receive them. The main goals of this project are: i) to improve our understanding of how cochlear implants affect the developing auditory system, ii) apply that knowledge to test new methods for programming children and adults, and iii) to study how long it takes listeners to adapt to new cochlear implant programs over the short- and long-term. The results will improve our understanding of how the deafened auditory system develops with cochlear implant stimulation and advance clinical practice to improve hearing outcomes in cochlear implant listeners.

02

Conditions studied

  • Deafness

Browse trials for

03

In context

Deafness

160 studies on the registry are indexed under Deafness; 46 are open to participants now.

This study's planned enrollment of 200 is above the median of 43 across 106 interventional studies indexed under Deafness.

Browse Deafness studies →

Lead sponsor

Massachusetts Eye and Ear Infirmary is the lead sponsor of 100 studies on the registry; 23 are open to participants now.

Of its 13 completed or terminated interventional studies of FDA-regulated products, 7 (54%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
3 Months and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Eligibility criteria

Inclusion Criteria:

Research Subjects with a Cochlear Implant ADULTS Inclusion Criteria

  • Adult at least 18 years old
  • Native speakers of American English
  • Wears a cochlear implant manufactured by Advanced Bionics (Clarion Hi-Focus I or newer), Cochlear, or MED-EL

CHILDREN Inclusion Criteria

  • Children at least 3 months old
  • Native speakers of American English
  • Wears a cochlear implant manufactured by Advanced Bionics (Clarion Hi-Focus I or newer), Cochlear, or MED-EL

    • For both children and adults with a cochlear implant, some study criteria might pertain to a subset of subjects, such as a specific age at which the subjects developed a hearing loss, or was implanted.

Exclusion Criteria:

Exclusion for all Cochlear Implant Subjects:

  • Inability to provide
  • Does not meet the inclusion criteria for a specific study protocol, such as age of onset of hearing loss, age of cochlear implantation, duration of deafness, number of active electrodes in the cochlear implant device
  • Unable to carry out the study protocol or tasks required in the study

Exclusion for all Normal Hearing Subjects:

  • Inability to provide informed consent
  • Hearing loss, or significant history of hearing related issues
  • Unable to carry out the study protocol or tasks required in the study
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Single group
Masking
Single (Participant)
Enrollment
200 participants (estimated)

Study arms

  • Experimental
    Performance Assessed with Experimental Sound Processing Strategy

    Patients listening to experimental cochlear implant processing strategy.

    Other: Experimental Speech Processing Strategy

  • No intervention
    Control

    Patients listening to their clinical cochlear implant using their "own" processor (their everyday listening situation).

  • Sham comparator
    Experimental Control

    Patients listening to experimental cochlear implant using a processing strategy like thier clinical program, a "clinical like" program.

    Other: Experimental Speech Processing Strategy

Interventions

  • OtherExperimental Speech Processing Strategy

    Patient's will listen with an experimental speech processor, programmed with a dynamic focusing strategy.

06

What researchers measure

Primary outcomes

  1. Slopes of the spread of excitation of the electrically evoked compound action potential responses

    Responses of the auditory nerve can be measured directly from the cochlear implant using software developed by the implant manufacturer. By changing the distance between two electrodes, we can quantify the spread of activation in the cochlea.

    Time frame: Baseline

  2. Slopes of a behavioral measure of spectral resolution called psychophysical tuning curves.

    A behavioral test designed to measure how spectral information is processed in the auditory system. By changing the relationship between a masker and target signal, we can assess resolution.

    Time frame: Baseline

  3. Changes in vowel identification scores

    Medial vowel identification performance in background noise. Participants will complete age-appropriate testing.

    Time frame: Baseline and weekly for 10 weeks after the intervention

  4. Changes in sentence recognition scores

    Speech perception testing includes sentence recognition in noise. Participants will complete age-appropriate testing.

    Time frame: Baseline and weekly for 10 weeks after the intervention

  5. Changes in speech-gap detection thresholds

    Speech perception testing includes speech-gap detection. Participants will complete age-appropriate testing.

    Time frame: Baseline and weekly for 10 weeks after the intervention

  6. Changes in phoneme discrimination scores

    Speech perception testing includes phoneme discrimination. Participants will complete age-appropriate testing.

    Time frame: Baseline and weekly for 10 weeks after the intervention

  7. Changes in time (weeks) with programming strategy

    Outcome measures will be obtained at weekly intervals during the intervention, and the weekly collection of those measures will be analyzed.

    Time frame: Baseline and weekly for 10 weeks after the intervention

Secondary outcomes

  1. Age

    A secondary age analysis on all outcome measures will be applied.

    Time frame: Age at baseline

  2. Infant-Toddler Meaningful Auditory Integration Scale (ITMAIS) scores

    The IT-MAIS is a study-team-guided parental report about how infants and toddlers are responding to sound.

    Time frame: Baseline, and weekly for 10 weeks after the intervention

  3. Macarthur-Bates vocabulary inventory scores

    This test allows the study team and parents to monitor speech and language development, specifically new word learning.

    Time frame: Baseline, and weekly for 10 weeks after the intervention

  4. Hearing quality of life (HEARQL) scores

    The HEAR-QL is a self-assessment test normed for children to assess how they hear in everyday life with different interventions

    Time frame: Baseline, 5 weeks, and 10 weeks after the intervention

  5. Sound quality questionnaire

    Participants will be asked to rate sound quality with different interventions in comparison to their everyday listening on a 7-point scale (from minus 3 - much worse, up to plus 3 - much better, 0 is the same)

    Time frame: Baseline and weekly for 10 weeks after the intervention

07

Study locations

2 of 2 sites recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 26, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05867173
Responsible party
Julie G. Arenberg, CCC-A (Director of Research and Education, Massachusetts Eye and Ear Infirmary) — Principal investigator
First posted
May 19, 2023
Start date
Sep 16, 2022
Primary completion
Mar 31, 2027 (estimated)
Completion
Mar 31, 2027 (estimated)
Last update
Nov 26, 2025

Study contacts

Julie Arenberg
Contact
julie_arenberg@meei.harvard.edu
617-807-7904
Julie Arenberg
principal investigator · Massachusetts Eye and Ear

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion